Serine Phosphorylation Sites on IRS2 Activated by Angiotensin II and Protein Kinase C To Induce Selective Insulin Resistance in Endothelial Cells
Kyoungmin Park(Joslin Diabetes Center), George L. King(Joslin Diabetes Center), Edward P. Feener(KalVista Pharmaceuticals (United States)), Jonathon N. Winnay(Joslin Diabetes Center), Akira Mima(Osaka University of Pharmaceutical Sciences), Morris F. White(Joslin Diabetes Center), Yasutaka Maeda(Kyushu University), Christian Rask‐Madsen(University of Ulsan), Katharine D’Aquino(Boston Children's Hospital), Koji Mizutani(Nagoya University), Qian Li(Shanghai Jiao Tong University)
Cited by 58
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307
|Journal of Biological Chemistry|2000|1.5k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k